AstraZeneca PLC (NASDAQ:AZN) Announces Strategic Collaboration Agreement With CSPC Pharmaceuticals

AstraZeneca PLC (NASDAQ:AZN) is one of the best long term low volatility stocks to invest in. AstraZeneca PLC (NASDAQ:AZN) announced on January 30 that it is bolstering its weight management portfolio through a new strategic collaboration agreement with CSPC Pharmaceuticals for the advancement of several next-generation therapies for obesity and type 2 diabetes across eight programmes.

AstraZeneca’s (AZN) Dividend: Resilient, Predictable, and Built on Innovation

The agreement entails the initial progress of four programmes by the companies, leveraging CSPC’s advanced AI-driven peptide drug discovery platform and their proprietary LiquidGel once-monthly dosing platform technology. AstraZeneca PLC (NASDAQ:AZN) reported that it would receive exclusive global rights outside of China to CSPC’s once-monthly injectable weight management portfolio, which includes one clinical-ready asset, SYH2082, a long-acting GLP1R/GIPR agonist progressing into Phase I, and three preclinical programmes with differing mechanisms designed to offer extended therapeutic benefits for people living with obesity and weight-related conditions.

Management further stated that the collaboration complements the company’s existing weight management portfolio, which encompasses an expanding pipeline of next-generation treatments addressing the complexities of obesity and weight-related complications, pursuing multiple modalities and pathways to specialize treatment based on individual needs. This includes elecoglipron (formerly AZD5004), a small molecule oral GLP1RA, AZD9550, a weekly injectable dual GLP-1/glucagon receptor agonist, and AZD6234, a weekly injectable selective amylin receptor agonist (SARA), along with several preclinical assets.

AstraZeneca PLC (NASDAQ:AZN) is a biopharmaceutical company that explores, develops, manufactures, and commercializes prescription medicines. It supplies its products and services to specialty and primary care physicians. AstraZeneca PLC (NASDAQ:AZN) distributes its products and services through local representative offices and distributors.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.